Upload Avatar (500 x 500)
Bin Wang
bwang3@fudan.edu.cn
Chinese, English
Shanghai
Fudan University
Basic Medical Sciences
  • 1978-1982 Bachelor's in Biology: Shandong University
  • 1984-1989 Ph.D. in Medicine: University of Cincinnati College of Medicine
  • 1989-1992 Postdoctoral Research: Wistar Institute
  • 1982-1984 - Chinese Academy of Sciences, Institute of Zoology - Assistant Researcher
  • 1992-1994 - University of Pennsylvania School of Medicine - Instructor
  • 1993-1998 - Apollon Inc. - Scientific Advisor
  • 1995-1998 - University of Pennsylvania School of Medicine, Department of Pathology - Assistant Professor
  • 2001-2002 - Xinjiang University, School of Life Sciences and Technology - Distinguished Professor
  • 2003-2010 - China Agricultural University - Distinguished Professor
  • 2010-Present - Fudan University, School of Basic Medical Sciences - Distinguished Professor
  • 2016-2020 - Director, National Engineering Laboratory for Therapeutic Vaccines
  • 2021-Present - Director, Fudan Vaccine Research and Translational Enterprise Joint Laboratory
  • National Science and Technology Plan Outstanding Team Award (11th Five-Year Plan)
  • Shanghai Patent Invention Gold Award (2015)
  • Scientific Chinese Person of the Year (2015)
  • Shanghai Patent Invention Gold Award (2018)
Research on new therapeutic and tolerogenic vaccines
Research on new vaccine adjuvants
Clinical immunology testing and new biomarkers
Mechanisms of immune tolerance and virus-host immune regulation
  • Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike protein, Sheng Jiang, Shuting Wu, Gan Zhao, Yue He, Xinrong Guo, Zhiyu Zhang, Jiawang Hou, Yuan Ding, Alex Cheng & Bin Wang, 2022
  • Comparison of Wild Type DNA Sequence of Spike Protein from SARS-CoV-2 with Optimized Sequence on The Induction of Protective Responses Against SARS-Cov-2 Challenge in Mouse Model, Sheng Jiang, Shuting Wu, Gan Zhao, Yue He, Linlin Bao, Jiangning Liu, Chuan Qin, Jiawang Hou, Yuan Ding, Alex Cheng, Brian Jiang, John Wu, Jian Yan, Laurent Humeau, Ami Patella, David B. Weiner, Kate Broderick & Bin Wang, 2021
  • Development of A Therapeutic Vaccine Targeting Merkel Cell Polyomavirus Capsid Protein VP1 against Merkel cell carcinoma, Dan Xu, Sheng Jiang, Yue He, Xiang Jin, Gan Zhao, and Bin Wang, 2021
  • Precise spatio-temporal interruption of regulatory T cell-mediated CD8+ T cell suppression leads to tumor immunity, Xiaoyu Zhou, Shushu Zhao, Yue He, Shuang Geng, Yan Shi, and Bin Wang, 2019
  • Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection, Feifei Yang, Xueping Yu, Chenliang Zhou, Richeng Mao, Mengqi Zhu, Haoxiang Zhu, Zhenxuan Ma, Bidisha Mitra, Gan Zhao, Yuxian Huang, Haitao Guo, Bin Wang, Jiming Zhang, 2019
  • Microneedles Improve The Immunogenicity Of DNA Vaccines, Shijie Zhang, Shushu Zhao, Xiang Jin, Bin Wang and Gan Zhao, 2018
  • Critical role of regulatory T cells in the latency and stress-induced reactivation of HSV-1, Wencong Yu, Shuang Geng, Yuanzhen Suo, Xunbin Wei, Qiliang Cai, Bing Wu, Xian Zhou, Yan Shi and Bin Wang, 2018
  • Revisiting GM-CSF as an adjuvant for therapeutic vaccines, Weidong Zhao, Gan Zhao, and Bin Wang, 2017
  • Biomarkers Distinguish HBeAg Seroconverted from Non-Converted Individuals in Chronic Hepatitis B Patients Treated with a Therapeutic Vaccine, Xian Zhou, Shuang Geng, Shijie Zhang, Weidong Zhao, Yumei Wen, Xuanyi Wang and Bin Wang, 2017
  • Induced regulatory T cells superimpose their suppressive capacity with effector T cells in lymph nodes via antigen-specific S1p1-dependent egress blockage, Shuang Geng, Yiwei Zhong, Xiaoyu Zhou, Gan Zhao, Xiaoping Xie, Yechun Pei, Hu Liu, Huiyuan Zhang, Yan Shi and Bin Wang, 2017
Therapeutic Vaccines Tolerogenic Vaccines Vaccine Adjuvants Clinical Immunology Biomarkers Immune Tolerance Virus-Host Interaction Immune Regulation Vaccine Development Immunotherapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.